 |
|
Short-term Effectiveness of Intravitreal Bevacizumab vs. Ranibizumab Injections for Patients with Polypoidal Choroidal Vasculopathy
Han Joo Cho, Ji Seon Baek, Dong Won Lee, Chul Gu Kim, Jong Woo Kim
Korean J Ophthalmol. 2012;26(3):157-162. Published online 2012 May 22 DOI: https://doi.org/10.3341/kjo.2012.26.3.157
|
|
Citations to this article as recorded by
 Efficacy and safety of anti-vascular endothelial growth agents for the treatment of polypoidal choroidal vasculopathy: A systematic review and meta-analysis
Amin Hatamnejad, Nikhil S. Patil, Andrew Mihalache, Marko M. Popovic, Peter J. Kertes, Rajeev H. Muni, David T. Wong
Survey of Ophthalmology.2023; 68(5): 920. CrossRef Effect of intravitreal injection of bevacizumab in treated and untreated eyes of Black African patients with polypoidal choroidal vasculopathy
N.N. Kabedi, D.L. Kayembe, J.C. Mwanza
Journal Français d'Ophtalmologie.2021; 44(10): 1505. CrossRef Cost-Utility Analysis of Drug Treatments in Patients with Polypoidal Choroidal Vasculopathy in Thailand
Sermsiri Sangroongruangsri, Usa Chaikledkaew, Prut Hanusaha, Tanapat Ratanapakorn, Paisan Ruamviboonsuk
ClinicoEconomics and Outcomes Research.2021; Volume 13: 917. CrossRef Polypoidal Choroidal Vasculopathy
Raquel Goldhardt, Bradley Simon Rosen
Current Ophthalmology Reports.2019; 7(1): 66. CrossRef A Multinational Comparison of Anti–Vascular Endothelial Growth Factor Use: The United States, the United Kingdom, and Asia-Pacific
Ravi Parikh, Nathan Pirakitikulr, Jay Chhablani, Yoichi Sakurada, Rishi P. Singh, Yasha S. Modi
Ophthalmology Retina.2019; 3(1): 16. CrossRef Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Patients With Neovascular Age-Related Macular Degeneration: Studies in Japan and the United States
Derek Kunimoto, Masahito Ohji, Raj K. Maturi, Tetsuju Sekiryu, Ying Wang, Grace Pan, Xiao-Yan Li, Susan Schneider
Ophthalmic Surgery, Lasers and Imaging Retina.2019;[Epub] CrossRef The Use of Vascular Endothelial Growth Factor Inhibitors and Complementary Treatment Options in Polypoidal Choroidal Vasculopathy: A Subtype of Neovascular Age-Related Macular Degeneration
Kelvin Teo, Mark Gillies, Samantha Fraser-Bell
International Journal of Molecular Sciences.2018; 19(9): 2611. CrossRef New Paradigms in Polypoidal Choroidal Vasculopathy Management: The Impact of Recent Multicenter, Randomized Clinical Trials
Colin S. Tan, Louis W. Lim, Seenu M. Hariprasad
Ophthalmic Surgery, Lasers and Imaging Retina.2018; 49(1): 4. CrossRef Comparing Ranibizumab and Aflibercept for Treatment of Polypoidal Choroidal Vasculopathy
Minkyung Song, Ah Ran Cho, Yoon Jeon Kim, June-Gone Kim, Young Hee Yoon, Joo Yong Lee
Journal of Retina.2018; 3(1): 49. CrossRef Polypoidal Choroidal Vasculopathy
Chui Ming Gemmy Cheung, Timothy Y.Y. Lai, Paisan Ruamviboonsuk, Shih-Jen Chen, Youxin Chen, K. Bailey Freund, Fomi Gomi, Adrian H. Koh, Won-Ki Lee, Tien Yin Wong
Ophthalmology.2018; 125(5): 708. CrossRef Polypoidal choroidal vasculopathy: Pearls in diagnosis and management
Giridhar Anantharaman, Jay Sheth, Muna Bhende, Raja Narayanan, Sundaram Natarajan, Anand Rajendran, George Manayath, Parveen Sen, Rupak Biswas, Alay Banker, Charu Gupta
Indian Journal of Ophthalmology.2018; 66(7): 896. CrossRef Polypoidal Choroidal Vasculopathy
Joon-Bom Kim, Rajinder S. Nirwan, Ajay E. Kuriyan
Current Ophthalmology Reports.2017; 5(2): 176. CrossRef Quantitative Changes in Pigment Epithelial Detachment Area and Volume Predict Retreatment in Polypoidal Choroidal Vasculopathy
Errol W. Chan, Mohab Eldeeb, Gopal Lingam, Doneal Thomas, Mayuri Bhargava, Caroline K. Chee
American Journal of Ophthalmology.2017; 177: 195. CrossRef Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians
Chee Wai Wong, Yasuo Yanagi, Won-Ki Lee, Yuichiro Ogura, Ian Yeo, Tien Yin Wong, Chui Ming Gemmy Cheung
Progress in Retinal and Eye Research.2016; 53: 107. CrossRef Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results
Gregg T. Kokame, James C. Lai, Raymond Wee, Ryan Yanagihara, Jessica G. Shantha, Julia Ayabe, Kelsi Hirai
BMC Ophthalmology.2016;[Epub] CrossRef Intravitreal Anti-vascular Endothelial Growth Factor for Newly Diagnosed Symptomatic Polypoidal Choroidal Vasculopathy with Extrafoveal Polyps
Jae Hui Kim, Dong Won Lee, Sung Chan Choi, Jong Woo Kim, Tae Gon Lee, Chul Gu Kim, Han Joo Cho
Korean Journal of Ophthalmology.2015; 29(6): 404. CrossRef Polypoidal Choroidal Vasculopathy in Asians
Chee Wong, Tien Wong, Chui Cheung
Journal of Clinical Medicine.2015; 4(5): 782. CrossRef Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
Alfredo García-Layana, Marta S. Figueroa, Javier Araiz, José M. Ruiz-Moreno, Francisco Gómez-Ulla, Luis Arias-Barquet, Nicholas Reiter
Drugs & Aging.2015; 32(10): 797. CrossRef Short-Term Efficacy of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy
Heon Yang, Hye Min Jeon, Sang Won Kim, Hee Seong Yoon, Woo Seok Choae
Journal of the Korean Ophthalmological Society.2015; 56(11): 1728. CrossRef Ranibizumab versus Bevacizumab for Ophthalmic Diseases Related to Neovascularisation: A Meta-Analysis of Randomised Controlled Trials
Bin Wu, Haixiang Wu, Xiaoyan Liu, Houwen Lin, Jin Li, Torben Lykke Sørensen
PLoS ONE.2014; 9(7): e101253. CrossRef Intravitreal Anti-vascular Endothelial Growth Factor for Typical Exudative Age-related Macular Degeneration in Eyes with Good Baseline Visual Acuity
Young Suk Chang, Jung Il Han, Su Jin Yoo, Young Ju Lew, Jae Hui Kim
Korean Journal of Ophthalmology.2014; 28(6): 466. CrossRef The Effects of Ranibizumab on Surgically Induced Endometriosis in a Rat Model: A Preliminary Study
Osman Sevket, Asli Sevket, Nur Buyukpinarbasili, Taner Molla, Gokhan Kilic, Seda Ates, Ramazan Dansuk
Reproductive Sciences.2013; 20(10): 1224. CrossRef Comparisons of Outcomes With Different Intervals Between Adjunctive Ranibizumab and Photodynamic Therapy for Polypoidal Choroidal Vasculopathy
Taku Sato, Shoji Kishi, Hidetaka Matsumoto, Ryo Mukai
American Journal of Ophthalmology.2013; 156(1): 95. CrossRef
|